MMC and VICC: Partnership for Survivorship (1 of 2)

MMC 和 VICC:幸存者合作伙伴关系(2 中的 1)

基本信息

  • 批准号:
    8540359
  • 负责人:
  • 金额:
    $ 19.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-23 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

The Meharry Medical College (MMC) and the Vanderbilt-lngram Cancer Center (VICC) propose to develop a new and innovative program centered on Cancer Survivorship Research and Cancer Survivorship Health Disparities. This is designed to be a sustainable and mutually beneficial program that significantly enhances the current Meharry-Vanderbilt Cancer Partnership (MVCP) funded U54, and efficiently utilizes already established resources. There are now over 11 million people in the United States living with a history of cancer with African Americans experiencing higher rates of mortality than do other racial/ethnic groups for reasons that are only partly understood. For cancer survivors, effects of the cancer treatment, lifestyle behaviors and environmental exposures can also lead to long-term morbidity and premature mortality. Yet, surprisingly little research has been conducted in "survivorship" to assess long term outcomes especially among adult cancer survivors, and in particular, minority survivor populations where baseline health disparities exist. Therefore, descriptive and analytic epidemiologic cohort studies are required to estimate the incidence of adverse physiologic and psychosocial long-term outcomes and evaluate their determinants to inform the development of best practices for preventive interventions. This proposal is designed to plan, prioritize and implement a series of collaborative pilot projects, using mixed methodologies with the following specific objectives: 1) To establish Cancer Survivorship research initiatives as a priority for the MVCP and integrate this area of research and clinical care into the existing partnership infrastructure; 2) To stimulate interactions and collaborations among faculty at MMC, VICC and a collaborating minority institution, Tennessee State University; 3) To stimulate research into the determinants of health disparities in cancer survivorship, including the biologic, socioeconomic, demographic and health-related risk factors associated with inferior survival of underserved populations (including populations of color, socio-economically challenged); and 4) To identify the incidence, prevalence, spectrum, and severity of adverse long-term health-related outcomes following cancer treatment and develop interventions to prevent or ameliorate such outcomes. The benefits of such an expanded partnership and program of research include for both MMC and VICC: 1) faculty development and recruitment with increased exposure to this line of research for trainees and junior faculty; 2) increases in pilot projects and ultimately competitive extramural funding that will now include research along the entire cancer control continuum; 3) expansion of the MVCP funded U54 and VICC support grant to include cancer survivorship research; 4) expansion of cancer health disparities research to include study of disparities in the quality and quantity of long-term survivorship; 5) facilitation of increased minority participation in cancer survivorship disparities research, with respect to both investigators and subjects.
梅哈里医学院(MMC)和范德比尔特英格拉姆癌症中心(VICC)提议开发一项以癌症生存研究和癌症生存健康差异为中心的新的创新项目。这是一个可持续和互利的计划,大大提高了目前的Meharry-Vanderbilt癌症合作伙伴关系(MVCP)资助的U 54,并有效地利用已经建立的资源。目前,美国有超过1100万人患有癌症,其中非洲裔美国人的死亡率高于其他种族/族裔群体,原因仅部分了解。对于癌症幸存者来说,癌症治疗的影响,生活方式行为和环境暴露也可能导致长期发病和过早死亡。然而,令人惊讶的是,很少有研究已经进行了“生存”,以评估长期的结果,特别是在成年癌症幸存者,特别是少数幸存者人群的基线健康差异存在。因此,需要描述性和分析性流行病学队列研究来估计不良生理和心理社会长期结果的发生率,并评估其决定因素,以告知预防干预措施的最佳实践的发展。该提案旨在规划、优先考虑和实施一系列合作试点项目,采用混合方法,具体目标如下:1)将癌症生存研究举措作为MVCP的优先事项,并将该研究和临床护理领域纳入现有的伙伴关系基础设施; 2)促进MMC、VICC和合作的少数民族机构田纳西州立大学教师之间的互动和合作; 3)促进对癌症生存率健康差异的决定因素的研究,包括生物学,社会经济,与得不到充分服务的人群生存率低相关的人口统计学和健康相关风险因素(包括有色人种、社会经济困难人群); 4)确定癌症治疗后不良长期健康相关结局的发生率、患病率、范围和严重程度,并制定干预措施以预防或改善此类结局。这种扩大的合作伙伴关系和研究计划的好处包括MMC和VICC:1)教师发展和招聘,增加学员和初级教师对这一研究领域的接触; 2)增加试点项目和最终竞争性的校外资金,现在将包括沿着整个癌症控制连续体的研究; 3)扩大MVCP资助的U 54和VICC支持补助金,将癌症生存研究纳入其中; 4)扩大癌症健康差异研究,将长期生存质量和数量差异的研究纳入其中; 5)促进少数群体参与癌症生存差异研究,无论是研究者还是受试者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John J. Murray其他文献

988-7 Endothelin ET<sub>A/B</sub> Receptor Antagonist Reduces Infarct Size: A Novel Therapy for Acute Myocardial Infarction
  • DOI:
    10.1016/0735-1097(95)92747-s
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Joao V. Vitolaf;John Holsinger;Menryn B. Forman;Edwin K. Jackson;Masatoshi Kawana;Thomas Quertermous;John J. Murray
  • 通讯作者:
    John J. Murray
923-1 Inhibition of Neutrophil Function by Lidocaine as a Mechanism for the Beneficial Effect to Reduce Myocardial Reperfusion Injury
  • DOI:
    10.1016/0735-1097(95)91878-2
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    João V. Vitola;John P. Holsinger;James Atkinson;Mervyn B. Forman;John J. Murray
  • 通讯作者:
    John J. Murray
923-3 Fluosol Reduces Myocardial Reperfusion Injury by Prolonged Suppression of Neutrophils by its Detergent Component (RheothRx) and not by Enhancing O<sub>2</sub>Delivery
  • DOI:
    10.1016/0735-1097(95)91880-7
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    João V. Vitola;David A. Ingram;John P. Holsinger;James B. Atkinson;Mervyn B. Forman;John J. Murray
  • 通讯作者:
    John J. Murray
Efficacy and Safety of a Novel, Single-dose Azithromycin Microsphere Formulation Versus 10 Days of Levofloxacin for the Treatment of Acute Bacterial Sinusitis in Adults
  • DOI:
    10.1016/j.otohns.2005.04.020
  • 发表时间:
    2005-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    John J. Murray;Paz Emparanza;Eugenijus Lesinskas;Margaret Tawadrous;Jeanne D. Breen
  • 通讯作者:
    Jeanne D. Breen
Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D.
播散性组织胞浆菌病中的高钙血症。
  • DOI:
    10.1016/0002-9343(85)90300-6
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    0
  • 作者:
    John J. Murray;Craig R. Heim
  • 通讯作者:
    Craig R. Heim

John J. Murray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John J. Murray', 18)}}的其他基金

Center for Cardiovascular Health Disparities Research at Meharry Medical College
梅哈里医学院心血管健康差异研究中心
  • 批准号:
    8289433
  • 财政年份:
    2011
  • 资助金额:
    $ 19.4万
  • 项目类别:
Center for Cardiovascular Health Disparities Research at Meharry Medical College
梅哈里医学院心血管健康差异研究中心
  • 批准号:
    8083231
  • 财政年份:
    2011
  • 资助金额:
    $ 19.4万
  • 项目类别:
PARTICIPANT AND CLINICAL INTERACTIONS RESOURCE (PCIR)
参与者和临床互动资源 (PCIR)
  • 批准号:
    8359880
  • 财政年份:
    2011
  • 资助金额:
    $ 19.4万
  • 项目类别:
MULTIDISCIPLINARY TRAINING AND CAREER DEVELOPMENT ACTIVITIES
多学科培训和职业发展活动
  • 批准号:
    8359876
  • 财政年份:
    2011
  • 资助金额:
    $ 19.4万
  • 项目类别:
MMC and VICC: Partnership for Survivorship (1 of 2)
MMC 和 VICC:幸存者合作伙伴关系(2 中的 1)
  • 批准号:
    8326219
  • 财政年份:
    2010
  • 资助金额:
    $ 19.4万
  • 项目类别:
MULTIDISCIPLINARY TRAINING AND CAREER DEVELOPMENT ACTIVITIES
多学科培训和职业发展活动
  • 批准号:
    8173600
  • 财政年份:
    2010
  • 资助金额:
    $ 19.4万
  • 项目类别:
PARTICIPANT AND CLINICAL INTERACTIONS RESOURCE (PCIR)
参与者和临床互动资源 (PCIR)
  • 批准号:
    8173604
  • 财政年份:
    2010
  • 资助金额:
    $ 19.4万
  • 项目类别:
Meharry Medical College Minority-Based Community Clinical Oncology Program
梅哈里医学院少数民族社区临床肿瘤学项目
  • 批准号:
    8511579
  • 财政年份:
    2004
  • 资助金额:
    $ 19.4万
  • 项目类别:
Meharry Medical College Minority-Based Community Clinical Oncology Program
梅哈里医学院少数民族社区临床肿瘤学项目
  • 批准号:
    8308753
  • 财政年份:
    2004
  • 资助金额:
    $ 19.4万
  • 项目类别:
ADENOSINE AND ENDOTHELIN IN MYOCARDIAL REPERFUSION
心肌再灌注中的腺苷和内皮素
  • 批准号:
    2219767
  • 财政年份:
    1988
  • 资助金额:
    $ 19.4万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 19.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了